| Title | Author(s) | Year | View Count |
 | MyelomA genetics international consortium | Morgan, G; Johnsen, HE; Goldschmidt, H; Palumbo, A; Cavo, M; Sonneveld, P; Miguel, JS; Chim, CS; Browne, P; Einsele, H; Waage, A; Turesson, I; Spencer, A; Hajek, R; Ludwig, H; Hemminki, K; Houlston, R | 2012 | 64 |
 | MAGIC (MyelomA Genetics International Consortium) | Morgan, G; Johnsen, HE; Goldschmidt, H; Palumbo, A; Cavo, M; Sonneveld, P; San Miguel, JF; Chim, JCS; Browne, PV; Einsele, H; Waage, A; Hajek, R; Ludwig, H; Turesson, I; Spencer, A; Hemminki, K | 2012 | 49 |
| International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation | Palumbo, A; Sezer, O; Kyle, R; Miguel, JS; Orlowski, RZ; Moreau, P; Niesvizky, R; Morgan, G; Comenzo, R; Sonneveld, P; Kumar, S; Hajek, R; Giralt, S; Bringhen, S; Anderson, KC; Richardson, PG; Cavo, M; Davies, F; Bladé, J; Einsele, H; Dimopoulos, MA; Spencer, A; Dispenzieri, A; Reiman, T; Shimizu, K; Lee, JH; Attal, M; Boccadoro, M; Mateos, M; Chen, W; Ludwig, H; Joshua, D; Chim, J; Hungria, V; Turesson, I; Durie, BGM; Lonial, S | 2009 | 89 |
|
